TRIZAL study: switching from successful HAART to Trizivir (abacavir-lamivudine-zidovudine combination tablet): 48 weeks efficacy, safety and adherence results.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples